We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ORLANDO, Fla. — Glenoid-related problems and infections occurred in 32% and 22%, respectively, of 139 revision surgeries performed following reverse total shoulder arthroplasty in 1,438 patients, according to findings presented at the American Academy of Orthopaedic Surgeons Annual Meeting.
Investigators from Germany and Australia studied the outcomes of 83 women and 56 men who underwent primary reverse shoulder arthroplasty (RSA) between 2008 and 2014.
“Complication in RSA leads to a significantly reduced outcome, but it is still acceptable if the prosthesis is retained. Removal of the implant after a time of instability, infection and loosening leaves the patient over time with poor results.” Michael J. Koch, MD, of Munich, who presented the results, said.
Michael J. Koch
Ninety of the index procedures were performed at Koch’s institution, and 49 patients were referred.
“Almost one-third of our patients needed more than one intervention,” he said.
Koch and colleagues retrospectively evaluated why the revisions were needed, as well as outcomes through 2 years and any associated complications.
“In our data, glenoid-associated complication was the number one reason with 32%,” he said.
Among the other reasons revision procedures were needed included instability (25 patients), scapular spine fractures (17 patients) and periprosthetic humeral fractures (11 patients). Humeral fractures were treated with either open reduction and internal fixation or prosthesis exchange.
“Time from reverse to revision was 28 months, average,” Koch said.
For the infection cases, the standard procedure surgeons used was a two-stage exchange, he noted. Instability was highly correlated with proximal bone loss, and investigators used 3-D CT to assess the bone quality in those cases, according to Koch.
Even in the face of a high complication rate, investigators noted the subjective shoulder value and Constant scores used to evaluate patients’ outcomes improved in all the patients at a mean follow-up of 3.2 years. – by Susan M. Rapp
Reference:
Koch MJ, et al. Paper #299. Presented at: American Academy of Orthopaedic Surgeons Annual Meeting; March 1-5, 2016; Orlando, Fla.
Disclosure: Koch reports no relevant financial disclosures.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.